Conservative management of upper urinary tract tumors

被引:65
作者
Deligne, E [1 ]
Colombel, M [1 ]
Badet, L [1 ]
Taniere, P [1 ]
Rouviere, O [1 ]
Dubernard, JM [1 ]
Lezrek, M [1 ]
Gelet, A [1 ]
Martin, X [1 ]
机构
[1] Hop Edouard Herriot, Serv Urol & Chirurg Transplantat, Serv Radiol, Serv Anat Pathol, F-69437 Lyon 03, France
关键词
transitional cell carcinoma; upper urinary tract; ureteroscopy; nephroscopy; percutaneous; endoscopic surgery; prognosis;
D O I
10.1016/S0302-2838(02)00220-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We determined the immediate and long-term results of endoscopic management of upper tract transitional cell in regard to rates of tumor recurrence and preservation of renal function. Materials and Methods: From January 1990 to July 1999, 61 patients (mean age 66.2 years) underwent endoscopic management of upper tract cell carcinoma. Of the patients 20 (32%) had a solitary kidney. Tumors were resected in a one time procedure by ureteroscopy only in 31.5%, by percutaneous nephroscopy in 29% or both in 8%; multiple treatment was necessary in 31.5% of cases using percutaneous nephroscopy only. Results: Immediate nephrectomy was done in six cases for high grade (three patients), insufficient local control (two cases) or patient's choices (one case). There were six cases of benign tumors excluded from survival Kaplan Meier analysis. With a mean follow-up of 39.9 months, the rate of kidney preservation, recurrence free rate, global survival and specific survival rates were, respectively, 81%, 68%, 77%, and 84%. Conclusions: Nephron sparing percutaneous management of upper tract cell carcinoma is applicable in a significant number of patients with a filling defect of upper urinary tract TCC. In carefully selected patients the results are at least comparable to other forms of management of tumor control and preservation of renal function. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 26 条
[1]  
AULD CD, 1984, BRIT J UROL, V56, P485
[2]   Fibroepithelial polyp of the renal pelvis: Nephron-sparing surgery after false-positive biopsy for transitional cell carcinoma [J].
Brady, JD ;
Korman, HJ ;
Civantos, F ;
Soloway, MS .
UROLOGY, 1997, 49 (03) :460-464
[3]   Surveillance of upper urinary tract transitional cell carcinoma: The role of ureteroscopy, retrograde pyelography, cytology and urinalysis [J].
Chen, GL ;
El-Gabry, EA ;
Bagley, DH .
JOURNAL OF UROLOGY, 2000, 164 (06) :1901-1904
[4]   13-year experience with percutaneous management of upper tract transitional cell carcinoma [J].
Clark, PE ;
Streem, SB ;
Geisinger, MA .
JOURNAL OF UROLOGY, 1999, 161 (03) :772-775
[5]   Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma [J].
Elliott, DS ;
Blute, ML ;
Patterson, DE ;
Bergstralh, EJ ;
Segura, JW .
UROLOGY, 1996, 47 (06) :819-825
[6]   TRANSITIONAL CELL-CARCINOMA OF UPPER URINARY-TRACT - SOME PROGNOSTIC INDICATORS [J].
GAWLEY, WF ;
HARNEY, J ;
GLACKEN, P ;
HEHIR, M ;
ROGERS, A ;
MCKELVIE, G .
UROLOGY, 1989, 33 (06) :459-461
[7]   Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies [J].
Grasso, M ;
Fraiman, M ;
Levine, M .
UROLOGY, 1999, 54 (02) :240-246
[8]   Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients [J].
Hall, MC ;
Womack, S ;
Sagalowsky, AI ;
Carmody, T ;
Erickstad, MD ;
Roehrborn, CG .
UROLOGY, 1998, 52 (04) :594-601
[9]  
HAYAKAWA M, 1981, Keio Journal of Medicine, V30, P97
[10]   Upper tract tumors in patients with primary bladder cancer followed for 15 years [J].
Herr, HW ;
Cookson, MS ;
Soloway, SM .
JOURNAL OF UROLOGY, 1996, 156 (04) :1286-1287